Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 6/20 | 0.52 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.52 |
| ▸ | NTSR2 | O95665 | 5/20 | 0.50 |
| ▸ | NTSR1 | P30989 | 5/20 | 0.50 |
| ▸ | SORT1 | Q99523 | 4/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29380132 | 1.00 | OPRD1 (0.52) | OPRD1OPRM1NTSR2NTSR1SORT1 | |
| SCHEMBL29392625 | 0.97 | OPRD1 (0.54) | OPRD1OPRM1NTSR2NTSR1SORT1 | |
| SCHEMBL31121205 | 0.97 | OPRD1 (0.55) | OPRD1OPRM1NTSR2NTSR1SORT1 | |
| SCHEMBL29379978 | 0.97 | OPRD1 (0.55) | OPRD1OPRM1NTSR2NTSR1SORT1 | |
| SCHEMBL30503059 | 0.94 | OPRD1 (0.56) | OPRD1OPRM1NTSR2NTSR1SORT1 | |
| SCHEMBL30116357 | 0.94 | OPRD1 (0.56) | OPRD1OPRM1NTSR2NTSR1SORT1 | |
| SCHEMBL30439746 | 0.94 | OPRD1 (0.56) | OPRD1OPRM1NTSR2NTSR1SORT1 | |
| SCHEMBL29392400 | 0.94 | OPRD1 (0.56) | OPRD1OPRM1NTSR2NTSR1SORT1 | |
| SCHEMBL29380576 | 0.94 | OPRM1 (0.59) | OPRD1OPRM1NTSR2NTSR1SORT1 | |
| SCHEMBL29532282 | 0.94 | OPRM1 (0.52) | OPRD1OPRM1NTSR2NTSR1SORT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250297282-A1 | VIRAL-BINDING PROTEIN AND RELATED REAGENTS, ARTICLES, AND METHODS OF USE | JUNO THERAPEUTICS GMBH (DE) | 2025-09-25 | — | — | US | disclosed |
| US-20250283037-A1 | METHODS FOR STIMULATING AND TRANSDUCING T CELLS | JUNO THERAPEUTICS GMBH (DE) | 2025-09-11 | — | — | US | disclosed |